The FDA's proposed upgrade to its off-label distribution guidelines has some new features, but experts say it is unclear if this means more dollars will flow toward reprints.
A month after UBM Canon closed the B2B magazine, marketing firm Outcomes LLC announced its return to twice-a-year publication.
The agency says outlets need to rethink running ads that make false claims.
Our year-end list captures the 10 that sparked heaviest interest.
The move to digitize a series of books it co-created with Disney for kids with type 1 diabetes was spurred by a meeting with the online diabetes community.
Elsevier is taking a hard-line posture against several different universities, asking them to take down scholarly research.
The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.
EHRs could be a vehicle for pharma to find its way into the physician's workflow. First, industry needs to learn how to leverage them appropriately.
American Medical News's 55-year publishing history ended September 2, although the website will be maintained through the end of the year.
A research team found that Big Pharma has pulled back on publications despite doubling or even quadrupling research and development budgets